Picture of VIA Pharmaceuticals logo

VIAP VIA Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for VIA Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2006
December 31st
2007
December 31st
2008
December 31st
2009
December 31st
2010
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.63-21.8-20.3-21-9.6
Depreciation
Non-Cash Items0.4530.9521.328.222.45
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0391.82-0.140.7640.966
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-8.16-18.9-18.9-11.9-6.11
Capital Expenditures-0.147-0.271-0.141-0.0160
Purchase of Fixed Assets
Other Investing Cash Flow Items010.800.0010
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.14710.5-0.141-0.0160
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities11.228.20104
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.8919.8-19-1.87-2.11